Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

388 results for Pharmaceuticals
Filters
Refine your search
CLEAR ALL
Actylis
Excipient for use in pharmaceutical applications. It acts as a preservative.
Actylis
Excipient developed for pharmaceutical applications. It acts as a preservative. 
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient recommended for pharmaceutical applications.
Actylis
Excipient for use in pharmaceutical applications. It acts as a preservative. 
Actylis
Excipient developed for injectable formulations. It functions as a preservative/antimicrobial. Benefits:
  • Maintains a low level of endotoxins with the bioburden limits (BET/MLT etc)
Actylis
Excipient designed for pharmaceutical applications.
Actylis
Excipiteent having possible use in pharmaceutical applications.
Actylis
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for use in pharmaceutical applications. It acts as an antioxidant.
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient designed for pharmaceutical applications.
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient developed for pharmaceutical applications.